Graphtx
Vienna, AT · 5 known investors
GraphTx is an AI-driven platform for drug discovery that validates immunology and inflammation drug targets using live patient samples before clinical trials. The company serves pharmaceutical researchers by applying machine learning to patient immune cell data to reduce development risk and failure rates.